Form 4 for CYTK CYTOKINETICS INC
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-02 · accession 0001061983-22-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-02 | CYTK | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +20.0K | 26.2K | +323% | $0 |
| DM | 2022-03-03 | 2022-03-02 | CYTK | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $37.63 | +45.0K | 13.3K | New | +$1.69M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-02 | A | A | 20,000 | $0.00 | 26,196 | D | — | — | |
| 2 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-03-02 | A | A | 31,715 | $37.63 | 31,715 | D | $37.63 · — to 2032-03-01 | 31,715 Common Stock | (F2) This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. |
| 3 | Derivative | Incentive Stock Option (right to buy) | 2022-03-02 | A | A | 13,285 | $37.63 | 13,285 | D | $37.63 · — to 2032-03-01 | 13,285 Common Stock | (F2) This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. |